Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ZetaSet
- Development stage
- Preclinical
- Lead developer
- ZetaGen
- Administration
- Intratumoral, Local
01
Overview
ZetaSet is a synthetic, osteo-inductive biologic developed by Zetagen Therapeutics. It is designed for the treatment of osteoporotic fractures, high energy injuries with bone defects, and fractures of the tibial plateau (knee) and plafond (ankle).
- Brand names
- ZetaSet
Beyond the preview
Go deeper on ZetaSet.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ZetaSet.